BUY Max Healthcare Institute Limited — Somil Mehta, Sharekhan
bySomil Mehta, SharekhanHorizon: NA (inferred Swing (≤2wk))2 Nov 2026via CNBC Awaaz.
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
AI Assessment
Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.
MACD above its signal line — bullish momentum
Technicals · macd·7 Nov · today
Max Healthcare reported Q2 revenue of Rs. 3,219 crore, a 20% year-on-year increase, and a profit after tax of Rs. 448 crore, representing 10% year-on-year growth.
BSE · Company Update·30 Oct · 1w ago
Max Healthcare reported Q2 revenue of Rs 3219 crore, up 20% YoY, and a PAT of Rs 448 crore, up 10% YoY.
NSE · Press Release·30 Oct · 1w ago
Max Healthcare reported Q2 FY27 financial results, approved capital expenditure of ~190 Crore for hospital expansions in Noida and Vaishali, and updated the project cost for its Gurugram hospital to ~
BSE · Board Meeting·30 Oct · 1w ago
Max Healthcare reported consolidated financial results for the quarter and half-year ended September 30, 2026, alongside approval for capital expenditure of approximately 190 crore for hospital expans
NSE · Outcome of Board Meeting·30 Oct · 1w ago
Nothing found in this tip’s window yet.
RSI at 79 — overbought territory
Technicals · rsi·7 Nov · today
1 advisor has an active short-term SELL call on this stock
Advisor consensus · adjacent horizon·13 Oct · 4w ago
Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.
Other calls on Max Healthcare Institute
- BUY — Jefferies India4 Nov 2026 · ~1 year · target ₹1,200 · Active
- BUY — Prakash Gaba4 Nov 2026 · Same day · target ₹940 · Expired
- BUY — Axis Securities4 Nov 2026 · ~1 year · target ₹1,110 · Active
- BUY — ICICI Securities4 Nov 2026 · ~1 year · target ₹1,300 · Active
- BUY — Nuvama Wealth4 Nov 2026 · ~1 year · target ₹1,035 · Active
More from Somil Mehta, Sharekhan
- BUY Navin Fluorine International6 Nov 2026 · ~3 months · target ₹10,000 · Active
- BUY State Bank of India6 Nov 2026 · Next day · target ₹1,080 · Active
- BUY Havells India6 Nov 2026 · ~2 weeks · target ₹1,200 · Active
- BUY KPIT Technologies5 Nov 2026 · Next day · target ₹580 · Active
- BUY BIRLASOFT5 Nov 2026 · ~3 months · target ₹380 · Active

